Approvals (Drugs@FDA)

KLYGEFA

ALEXION PHARM · GEFURULIMAB-GAKS

BLA761488Biologic (BLA)Prescription
Open FDA's page for this record
Application number
BLA761488
Sponsor name
ALEXION PHARM
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20261113
    Review priority
    STANDARD
    Submission class code
    TYPE 1
    Submission class code description
    Type 1 - New Molecular Entity
    Submission property type
    1. Code
      Orphan
    Application docs
    1. ID
      87700
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761488s000lbl.pdf
      Date
      20261113
      Type
      Label
    2. ID
      87733
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761488Orig1s000ltr.pdf
      Date
      20261117
      Type
      Letter
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    KLYGEFA
    Reference standard
    No
    Dosage form
    SOLUTION
    Route
    INJECTION
    Marketing status
    Prescription
    Active ingredients
    1. Name
      GEFURULIMAB-GAKS
      Strength
      300MG
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.